Monoclonal antibodies conjugated with fluorescein permitted rapid, strainspecific identification of influenza A isolates and type-specific identification of influenza B isolates by direct immunofluorescence staining. Identification of Hi influenza A strains could be accomplished by direct immunofluorescence on cell culture fluids lacking sufficient hemagglutinin activity to permit identification by hemagglutination inhibition.
Monoclonal antibodies conjugated with fluorescein permitted rapid, strainspecific identification of influenza A isolates and type-specific identification of influenza B isolates by direct immunofluorescence staining. Identification of Hi influenza A strains could be accomplished by direct immunofluorescence on cell culture fluids lacking sufficient hemagglutinin activity to permit identification by hemagglutination inhibition.
Influenza viruses were among the first to which monoclonal antibodies were applied for more definitive antigenic analyses, and these immune reagents proved to be extremely sensitive tools for antigenic mapping of viruses and for defining antigenic drifts (3, (7) (8) (9) .
In efforts to speed and facilitate the identification of influenza virus isolates, monoclonal antibodies to recent influenza A and B strains were produced and examined for suitability in direct immunofluorescence (DIF) staining for strainspecific identification of current and recent viral isolates.
Viruses used for antibody production were the AlBerkeley/1/80 H3N2 strain ( Table 1 . HI tests were performed by standard procedures (1) , and the indirect immunoperoxidase (5) and indirect immunofluorescence (2) methods have also been described. The three reagents reacted to varying titers with homologous viruses, and showed no reactivity with heterologous ones. By indirect immunoperoxidase staining the H3N2 reagent reacted with the homologous strain and the A/Bangkok/1/79 strain, but failed to react with the earlier H3N2 strains, A/Hong Kong/5/2 and A/Texas/1/77.
The influenza B reagent showed no HI activity, but high type-specific titers by indirect immunoperoxidase and indirect immunofluorescence, indicating that it was directed against a typespecific viral component rather than the hemagglutinin. None of the monoclonal antibody preparations showed complement-fixing activity with homologous antigens.
For virus identification by DIF staining, the monoclonal antibodies in immune ascitic fluids were labeled with fluorescein isothiocyanate (2) , and the conjugates were titrated against monkey kidney cells infected with homologous and heterologous viruses to determine the optimal Identification was based upon staining with one of the strain-specific influenza A monoclonal antibody conjugates and the standard influenza A conjugate, or with the monoclonal and standard influenza B conjugates. In the initial phase of this study, confirmatory identification was done by HI with antisera prepared in hamsters. DIF staining with the monoclonal antibody conjugates clearly identified the isolates as Hi or H3 strains of influenza A, or as influenza B viruses (Table 2 ). Identification by DIF was accomplished on day 3 to 5 after inoculation for the HI strains, at day 3 for the H3 strains, and on days 3 to 5 for the influenza B strains. DIF was particularly useful for identification of the Hi influenza A isolates, since these strains had low hemagglutinin titers in the cell culture fluids, often requiring additional passages before identification could be accomplished by HI. Even then, cell culture fluids frequently contained fewer than 4 hemagglutinating units optimal for use in an HI test.
The ability to perform strain-specific identification of influenza virus isolates by more rapid and simpler methods than HI is very useful for epidemiological surveillance in the current situation, where influenza A HlNl and H3N2 strains In addition to their sharp specificity, other advantages of hybridoma-derived monoclonal antibodies are the facts that they are available in virtually unlimited quantities from frozen stocks of antibody-producing hybrid cells and that the conjugates of immune ascitic fluids can be used at remarkably high dilutions as compared to standard antiserum conjugates, providing a large and consistent supply of the immune reagents.
It must be recognized, however, that the narrow specificity of monoclonal antibodies may be a drawback as well as an advantage. If antigenic drift in the hemagglutinin of an influenza A virus were to involve the determinant against which the monoclonal antibody is directed, the conjugate would no longer be useful for identification. However, this would not lead to an incorrect identification if a type-reactive influenza A conjugate were included in the identification scheme; staining with this conjugate, but not with a strain-specific one, would indicate that the isolate was an influenza A virus no longer covered by the strain-specific reagents, and new reagents to the current strain would have to be prepared.
